ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Live From WCLC 2024: Monday Highlights"
Episode Synopsis
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Narjust Florez discusses daily highlights from the conference.
Dr. Xiuning Le reports updated results of BAY 292708, and Dr. Gerrina Ruiter summarizes the Beamion LUNG-1 study, both of which evaluate the efficacy of therapies for patients with HER2-Mutant NSCLC. Dr. Fiona Hegi-Johnson adds her perspective as a discussant of the POLESTAR trial evaluating EGFR therapy after chemoradiation in stage III unresectable NSCLC.
Guests:
Dr. Fiona Hegi-Johnson
Radiation Oncologist at the Peter MacCallum Cancer Centre
Senior Research Fellow at the University of Melbourne
Dr. Xiuning Le, M.D., Ph.D.
Assistant Professor in the Department of Thoracic/Head and Neck Medical Oncology
University of Texas M.D. Anderson Cancer Center
Dr. Gerrina Ruiter, M.D., Ph.D.
Pulmonologist Specialized in Thoracic Oncology at the Netherlands Cancer Institute
Amsterdam, The Netherlands
Dr. Xiuning Le reports updated results of BAY 292708, and Dr. Gerrina Ruiter summarizes the Beamion LUNG-1 study, both of which evaluate the efficacy of therapies for patients with HER2-Mutant NSCLC. Dr. Fiona Hegi-Johnson adds her perspective as a discussant of the POLESTAR trial evaluating EGFR therapy after chemoradiation in stage III unresectable NSCLC.
Guests:
Dr. Fiona Hegi-Johnson
Radiation Oncologist at the Peter MacCallum Cancer Centre
Senior Research Fellow at the University of Melbourne
Dr. Xiuning Le, M.D., Ph.D.
Assistant Professor in the Department of Thoracic/Head and Neck Medical Oncology
University of Texas M.D. Anderson Cancer Center
Dr. Gerrina Ruiter, M.D., Ph.D.
Pulmonologist Specialized in Thoracic Oncology at the Netherlands Cancer Institute
Amsterdam, The Netherlands
More episodes of the podcast Lung Cancer Considered
LCC in Greek: WCLC 2025 Highlights
10/10/2025
LCC in Arabic: WCLC 2025 Highlights
03/10/2025
Lung Cancer Considered: Targeting EGFR NSCLC
03/10/2025
LCC in Korean: WCLC 2025 Highlights
30/09/2025
LCC in Portuguese: WCLC 2025 Highlights
16/09/2025
In God we trust